371 related articles for article (PubMed ID: 22149317)
21. [Coronary heart disease associated with the use of highly active antiretroviral therapy (HAART). A case report and review].
Neumann T; Kondratieva J; Eggebrecht H; Wieneke H; Esser S; Bartel T; Erbel R
Herz; 2005 Sep; 30(6):504-9. PubMed ID: 16170681
[TBL] [Abstract][Full Text] [Related]
22. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
Panel de expertos de GESIDA y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
[TBL] [Abstract][Full Text] [Related]
23. Key data from the 11th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV.
Boehme RE; Cameron S
Antivir Ther; 2009; 14(8):1195-208. PubMed ID: 20032550
[TBL] [Abstract][Full Text] [Related]
24. Cardiovascular risk among HIV-positive patients on antiretroviral therapy.
Aberg JA
J Int Assoc Physicians AIDS Care (Chic); 2003 Sep; 2 Suppl 2():S24-39. PubMed ID: 14569635
[TBL] [Abstract][Full Text] [Related]
25. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
26. Optimal antiretroviral therapy for aging.
Cordery DV; Cooper DA
Sex Health; 2011 Dec; 8(4):534-40. PubMed ID: 22127040
[TBL] [Abstract][Full Text] [Related]
27. [Controversies and future of the approach to cardiovascular disease in HIV patients].
Bernardino de la Serna JI; Arribas López JR
Enferm Infecc Microbiol Clin; 2009 Sep; 27 Suppl 1():48-53. PubMed ID: 20172415
[TBL] [Abstract][Full Text] [Related]
28. Therapy insight: Body-shape changes and metabolic complications associated with HIV and highly active antiretroviral therapy.
Falutz J
Nat Clin Pract Endocrinol Metab; 2007 Sep; 3(9):651-61. PubMed ID: 17710086
[TBL] [Abstract][Full Text] [Related]
29. HIV-related cardiovascular disease and drug interactions.
Nanavati KA; Fisher SD; Miller TL; Lipshultz SE
Am J Cardiovasc Drugs; 2004; 4(5):315-24. PubMed ID: 15449973
[TBL] [Abstract][Full Text] [Related]
30. Premature age-related comorbidities among HIV-infected persons compared with the general population.
Guaraldi G; Orlando G; Zona S; Menozzi M; Carli F; Garlassi E; Berti A; Rossi E; Roverato A; Palella F
Clin Infect Dis; 2011 Dec; 53(11):1120-6. PubMed ID: 21998278
[TBL] [Abstract][Full Text] [Related]
31. Antiretroviral therapy in HIV-infected children: the metabolic cost of improved survival.
Leonard EG; McComsey GA
Infect Dis Clin North Am; 2005 Sep; 19(3):713-29. PubMed ID: 16102657
[TBL] [Abstract][Full Text] [Related]
32. What happens to cardiovascular system behind the undetectable level of HIV viremia?
d'Ettorre G; Ceccarelli G; Pavone P; Vittozzi P; De Girolamo G; Schietroma I; Serafino S; Giustini N; Vullo V
AIDS Res Ther; 2016; 13():21. PubMed ID: 27127532
[TBL] [Abstract][Full Text] [Related]
33. Risk of cardiovascular disease in a cohort of HIV-infected adults: a study using carotid intima-media thickness and coronary artery calcium score.
Mangili A; Gerrior J; Tang AM; O'Leary DH; Polak JK; Schaefer EJ; Gorbach SL; Wanke CA
Clin Infect Dis; 2006 Dec; 43(11):1482-9. PubMed ID: 17083026
[TBL] [Abstract][Full Text] [Related]
34. [Spectrum of cardiovascular disease in HIV-infected patients].
Lozano F
Enferm Infecc Microbiol Clin; 2009 Sep; 27 Suppl 1():3-9. PubMed ID: 20172409
[TBL] [Abstract][Full Text] [Related]
35. [Interactions of cardiac and antiretroviral medication].
Egger S; Drewe J
Herz; 2005 Sep; 30(6):493-503. PubMed ID: 16170680
[TBL] [Abstract][Full Text] [Related]
36. HIV and hepatitis C co-infection: the role of HAART in HIV/hepatitis C virus management.
Jones M; Núñez M
Curr Opin HIV AIDS; 2011 Nov; 6(6):546-52. PubMed ID: 22001896
[TBL] [Abstract][Full Text] [Related]
37. [Cardiac manifestations in HIV-infected individual].
Neumann T; Ross B; Hengge UR; Gerken G; Erbel R
Med Klin (Munich); 2002 Nov; 97(11):659-65. PubMed ID: 12434274
[TBL] [Abstract][Full Text] [Related]
38. First Italian consensus statement on diagnosis, prevention and treatment of cardiovascular complications in HIV-infected patients in the HAART era (2006).
Carosi G; Quiros-Roldan E; Torti C; Antinori A; Bevilacqua M; Bonadonna RC; Bonfanti P; Castagna A; Cauda R; d'Arminio-Monforte A; Di Gregorio P; Di Perri G; Esposito R; Fatuzzo F; Gervasoni C; Giannattasio C; Guaraldi G; Lazzarin A; Lo Caputo S; Maggi P; Mazzotta F; Moroni M; Prestileo T; Ranieri R; Rizzardini G; Russo R; Galli M;
Infection; 2007 Jun; 35(3):134-42. PubMed ID: 17565453
[TBL] [Abstract][Full Text] [Related]
39. [HIV infection in France in 2012: reality, risks and challenges for a chronic multisystem disease].
Blot M; Piroth L
Rev Mal Respir; 2012 Jun; 29(6):785-92. PubMed ID: 22742465
[TBL] [Abstract][Full Text] [Related]
40. Pharmacologic consideration for the use of antiretroviral agents in the elderly.
Rhee MS; Greenblatt DJ
J Clin Pharmacol; 2008 Oct; 48(10):1212-25. PubMed ID: 18812611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
